IDP-LS05

General Information


DRACP ID  DRACP06156

Peptide Name   IDP-LS05

Sequence  RKRⓍNDLRSRⓍLALRDQ

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Stapled Peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic(stapled)

Disulfide/Other Bond  Stapled: Ⓧ(4) and Ⓧ (7) are cross-linked by hydrocarbon stapling

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  Ⓧ(4)=2-amino-2-methyl-6-decanoic acid; Ⓧ(7)=2-amino-2-methyl-9-heptenoic acid

Chiral  L



Physicochemical Information


Formula  C77H137N33O21

Absent amino acids  CEFGHIMPTVWY

Common amino acids  R

Mass  214671

Pl  12.33

Basic residues  6

Acidic residues  2

Hydrophobic residues  4

Net charge  4

Boman Index  -9660

Hydrophobicity  -164.71

Aliphatic Index  74.71

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN111511761A

Patent Title  Anticancer Peptides

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.